BR0214199A - Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração - Google Patents

Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração

Info

Publication number
BR0214199A
BR0214199A BR0214199-0A BR0214199A BR0214199A BR 0214199 A BR0214199 A BR 0214199A BR 0214199 A BR0214199 A BR 0214199A BR 0214199 A BR0214199 A BR 0214199A
Authority
BR
Brazil
Prior art keywords
administration
active agents
dosage unit
unit form
release active
Prior art date
Application number
BR0214199-0A
Other languages
English (en)
Inventor
David Gschneidner
Kelly Kraft
Yi Chen
Chen Zhu
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of BR0214199A publication Critical patent/BR0214199A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES DE FENóXI AMINA PARA LIBERAR AGENTES ATIVOS, FORMA DE UNIDADE DE DOSAGEM E MéTODO DE ADMINISTRAçãO". Compostos e composições de fenóxi amina para a entrega de agentes ativos são providos. Métodos de administração e preparação também são providos.
BR0214199-0A 2001-11-13 2002-11-13 Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração BR0214199A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35048801P 2001-11-13 2001-11-13
US35728802P 2002-02-15 2002-02-15
PCT/US2002/036552 WO2003045306A2 (en) 2001-11-13 2002-11-13 Phenoxy amine compounds and compositions for delivering active agents

Publications (1)

Publication Number Publication Date
BR0214199A true BR0214199A (pt) 2005-01-04

Family

ID=26996636

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214199-0A BR0214199A (pt) 2001-11-13 2002-11-13 Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração

Country Status (12)

Country Link
US (1) US7297794B2 (pt)
EP (1) EP1453816B1 (pt)
JP (1) JP4602668B2 (pt)
CN (1) CN1596248B (pt)
AU (1) AU2002360387B2 (pt)
BR (1) BR0214199A (pt)
CA (1) CA2465641C (pt)
ES (1) ES2431630T3 (pt)
MX (1) MXPA04004567A (pt)
NZ (1) NZ532597A (pt)
WO (1) WO2003045306A2 (pt)
ZA (1) ZA200403572B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2595697A (en) 1996-03-29 1997-10-22 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6991798B1 (en) 1998-08-07 2006-01-31 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
UA80248C2 (en) 2000-06-29 2007-09-10 Compounds and compositions for delivering active agents
JP4602668B2 (ja) 2001-11-13 2010-12-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するためのフェノキシアミン化合物および組成物
CN1332711C (zh) 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp－1分子的方法
US20040076587A1 (en) * 2002-06-19 2004-04-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical composition for intranasal administration containing a CGRP antagonist
US20060128615A1 (en) * 2002-09-18 2006-06-15 Pierrette Gaudreau Ghrh analogues
RU2006136790A (ru) * 2004-04-16 2008-05-27 Эмисфире Текнолоджис, Инк. (Us) 8-(2-гидроксифенокси)октилдиетаноламин и его соли для доставки активных агентов
CA2566161C (en) 2004-05-14 2013-10-01 Emisphere Technologies, Inc. Aryl ketone compounds and compositions for delivering active agents
WO2005112633A2 (en) 2004-05-14 2005-12-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
AU2005244986B2 (en) 2004-05-19 2011-01-27 Emisphere Technologies, Inc. Topical cromolyn formulations
US9345725B2 (en) 2004-12-29 2016-05-24 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
US8110547B2 (en) 2005-01-12 2012-02-07 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
US8975227B2 (en) 2005-07-15 2015-03-10 Emisphere Technologies, Inc. Intraoral dosage forms of glucagon
US7354952B2 (en) * 2005-11-04 2008-04-08 Genta Incorporated Pharmaceutical gallium compositions and methods
CN101384605A (zh) * 2006-02-15 2009-03-11 塞诺菲-安万特股份有限公司 新的氨基醇取代的芳基噻吩并嘧啶酮、其制备方法以及其作为药物的用途
BRPI0707869A2 (pt) * 2006-02-15 2011-05-10 Sanofi Aventis ariltienopirimidinonas substituÍdas com azaciclil, processo para a sua preparaÇço e seus usos como medicamentos
JP4857138B2 (ja) * 2006-03-23 2012-01-18 富士フイルム株式会社 レジスト組成物及びそれを用いたパターン形成方法
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
EP2007372B1 (en) 2006-04-18 2015-03-04 Emisphere Technologies, Inc. Dialkyl ether delivery agents
CA2656019C (en) 2006-06-28 2016-09-13 Emisphere Technologies, Inc. Gallium nitrate formulations
CA2661018C (en) 2006-08-18 2015-11-24 Emisphere Technologies, Inc. Synthesis of propyl phenoxy ethers and use as delivery agents
WO2008027958A2 (en) 2006-08-31 2008-03-06 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2008101240A1 (en) * 2007-02-16 2008-08-21 Emisphere Technologies, Inc. Compounds having a cyclic moiety and compositions for delivering active agents
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
MX368045B (es) 2012-08-23 2019-09-17 Emisphere Tech Inc Compuestos de diisopropanolamina y dietanolamina de fenoxialquilo para la administracion de agentes activos.
PT2897620T (pt) 2012-09-21 2020-09-03 Intensity Therapeutics Inc Método de tratamento de cancro
JP6925969B2 (ja) 2015-02-09 2021-08-25 エンテラ バイオ エルティーディー． 医薬組成物
CN104961687B (zh) * 2015-06-03 2017-07-25 苏州维泰生物技术有限公司 1,2‑二嗪衍生物及其制剂、用途
SG11201901070YA (en) 2016-08-17 2019-03-28 Entera Bio Ltd Formulations for oral administration of active agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH297705A (de) * 1950-09-16 1954-03-31 Cilag Ag Verfahren zur Herstellung eines neuen basischen Äthers.
GB710511A (en) * 1950-09-29 1954-06-16 Abbott Lab Improvements in or relating to aryl ethers of morpholino-alkanols and methods for the production thereof
GB1524260A (en) * 1976-11-23 1978-09-06 Beecham Group Ltd Aminoalkyloneoxyd substituted 4-hydroxy-3 nitrocoumarins
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
CA1315279C (en) * 1987-01-12 1993-03-30 Nancy Grace Bollinger Anti-inflammatory agents
US5023253A (en) * 1987-12-21 1991-06-11 University Patents, Inc. 6-substituted mitomycin analogs
KR920701167A (ko) 1989-07-07 1992-08-11 에릭 에스. 딕커 약제학적 활성 화합물
JPH0441472A (ja) * 1990-06-05 1992-02-12 Sankyo Co Ltd グアニジノ安息香酸エステル誘導体
JPH04117461A (ja) 1990-09-07 1992-04-17 Asahi Denka Kogyo Kk 耐光性の改善された高分子材料組成物
JP2000256286A (ja) * 1999-03-11 2000-09-19 Kaken Pharmaceut Co Ltd アルキルアミン誘導体
HK1048801B (en) * 1999-11-05 2009-08-28 Emisphere Technologies, Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
JP4602668B2 (ja) 2001-11-13 2010-12-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するためのフェノキシアミン化合物および組成物
RU2006136790A (ru) * 2004-04-16 2008-05-27 Эмисфире Текнолоджис, Инк. (Us) 8-(2-гидроксифенокси)октилдиетаноламин и его соли для доставки активных агентов
US9345725B2 (en) 2004-12-29 2016-05-24 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts

Also Published As

Publication number Publication date
CN1596248A (zh) 2005-03-16
WO2003045306A2 (en) 2003-06-05
US7297794B2 (en) 2007-11-20
EP1453816A4 (en) 2005-02-09
ZA200403572B (en) 2005-09-28
WO2003045306A3 (en) 2003-09-04
AU2002360387B2 (en) 2008-08-07
HK1069383A1 (en) 2005-05-20
US20050119502A1 (en) 2005-06-02
EP1453816A2 (en) 2004-09-08
CA2465641C (en) 2011-06-21
ES2431630T3 (es) 2013-11-27
JP2005519875A (ja) 2005-07-07
NZ532597A (en) 2006-04-28
JP4602668B2 (ja) 2010-12-22
CN1596248B (zh) 2012-05-09
EP1453816B1 (en) 2013-09-18
AU2002360387A1 (en) 2003-06-10
MXPA04004567A (es) 2004-09-10
CA2465641A1 (en) 2003-06-05

Similar Documents

Publication Publication Date Title
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
MXPA02002249A (es) Composiciones farmaceuticas agradables al paladar para animales de compania.
MXPA05013587A (es) Agentes terapeuticos utiles para el tratamiento del dolor.
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
SE9900961D0 (sv) Novel compounds
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
WO2002015959A3 (en) Compounds and compositions for delivering active agents
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
WO2002100338A3 (en) Compound and composition for delivering active agents
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
NZ523606A (en) Pharmaceutical compositions and methods for use
DE69828522D1 (de) Antithrombotische mittel
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
WO2005062874A3 (en) Compounds and compositions for delivering active agents

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: C07C 217/30, C07C 217/22, C07D 233/54, C07D 233/60, C07D 233/64, C07D 295/08, C07D 295/092, A61K 38/00, A61K 38/21, A61K 38/22, A61K 38/28, A61K 38/43, A61K 47/18, A61K 47/16, A61K 47/22, A61K 9/00

Ipc: C07D 265/30 (2011.01), C07D 265/32 (2011.01), C07D

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]